17-80099556-A-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_017950.4(CCDC40):ā€‹c.3210A>Gā€‹(p.Thr1070=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 1,611,218 control chromosomes in the GnomAD database, including 73,394 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.35 ( 10236 hom., cov: 31)
Exomes š‘“: 0.29 ( 63158 hom. )

Consequence

CCDC40
NM_017950.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -2.62
Variant links:
Genes affected
CCDC40 (HGNC:26090): (coiled-coil domain 40 molecular ruler complex subunit) This gene encodes a protein that is necessary for motile cilia function. It functions in correct left-right axis formation by regulating the assembly of the inner dynein arm and the dynein regulatory complexes, which control ciliary beat. Mutations in this gene cause ciliary dyskinesia type 15, a disorder due to defects in cilia motility. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 17-80099556-A-G is Benign according to our data. Variant chr17-80099556-A-G is described in ClinVar as [Benign]. Clinvar id is 162852.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-80099556-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-2.62 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.506 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CCDC40NM_017950.4 linkuse as main transcriptc.3210A>G p.Thr1070= synonymous_variant 20/20 ENST00000397545.9 NP_060420.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CCDC40ENST00000397545.9 linkuse as main transcriptc.3210A>G p.Thr1070= synonymous_variant 20/205 NM_017950.4 ENSP00000380679 P2Q4G0X9-1
CCDC40ENST00000574799.5 linkuse as main transcriptn.2747A>G non_coding_transcript_exon_variant 16/161

Frequencies

GnomAD3 genomes
AF:
0.350
AC:
53166
AN:
151880
Hom.:
10219
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.511
Gnomad AMI
AF:
0.335
Gnomad AMR
AF:
0.215
Gnomad ASJ
AF:
0.257
Gnomad EAS
AF:
0.425
Gnomad SAS
AF:
0.326
Gnomad FIN
AF:
0.334
Gnomad MID
AF:
0.350
Gnomad NFE
AF:
0.287
Gnomad OTH
AF:
0.327
GnomAD3 exomes
AF:
0.303
AC:
74940
AN:
247662
Hom.:
12200
AF XY:
0.305
AC XY:
41130
AN XY:
134636
show subpopulations
Gnomad AFR exome
AF:
0.517
Gnomad AMR exome
AF:
0.160
Gnomad ASJ exome
AF:
0.266
Gnomad EAS exome
AF:
0.409
Gnomad SAS exome
AF:
0.333
Gnomad FIN exome
AF:
0.328
Gnomad NFE exome
AF:
0.290
Gnomad OTH exome
AF:
0.309
GnomAD4 exome
AF:
0.288
AC:
420850
AN:
1459220
Hom.:
63158
Cov.:
36
AF XY:
0.290
AC XY:
210357
AN XY:
726066
show subpopulations
Gnomad4 AFR exome
AF:
0.519
Gnomad4 AMR exome
AF:
0.171
Gnomad4 ASJ exome
AF:
0.268
Gnomad4 EAS exome
AF:
0.453
Gnomad4 SAS exome
AF:
0.325
Gnomad4 FIN exome
AF:
0.339
Gnomad4 NFE exome
AF:
0.275
Gnomad4 OTH exome
AF:
0.307
GnomAD4 genome
AF:
0.350
AC:
53224
AN:
151998
Hom.:
10236
Cov.:
31
AF XY:
0.349
AC XY:
25909
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.511
Gnomad4 AMR
AF:
0.214
Gnomad4 ASJ
AF:
0.257
Gnomad4 EAS
AF:
0.425
Gnomad4 SAS
AF:
0.327
Gnomad4 FIN
AF:
0.334
Gnomad4 NFE
AF:
0.287
Gnomad4 OTH
AF:
0.331
Alfa
AF:
0.298
Hom.:
2972
Bravo
AF:
0.348
Asia WGS
AF:
0.388
AC:
1351
AN:
3478
EpiCase
AF:
0.279
EpiControl
AF:
0.276

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Thr1070Thr in exon 20 of CCDC40: This variant is not expected to have clinical s ignificance because it does not alter an amino acid residue and is not located w ithin the splice consensus sequence. It has been identified in 49.4% (1938/3920) of African American chromosomes from a broad population by the NHLBI Exome Sequ encing Project (http://evs.gs.washington.edu/EVS; dbSNP rs56407805). -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 07, 2014- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Primary ciliary dyskinesia Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsJul 07, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJul 05, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Primary ciliary dyskinesia 15 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Glycogen storage disease, type II Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.063
DANN
Benign
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs56407805; hg19: chr17-78073355; COSMIC: COSV56410864; COSMIC: COSV56410864; API